Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$538.60 -4.02 (-0.74%)
At close: Nov 13, 2026 · 4:00 PM EST

Vertex Pharmaceuticals (VRTX) Other Accumulated Expenses (2009 - 2026)

Updated

Vertex Pharmaceuticals (VRTX) posted Other Accumulated Expenses of $293 million for Q3 2026, down 33.6% from $441.5 million a year earlier and down 11.1% from the prior quarter.

Analysis

Vertex Pharmaceuticals (VRTX) Other Accumulated Expenses (2009 - 2026) Analysis & Trends

At the end of FY2025, Vertex Pharmaceuticals' Other Accumulated Expenses came in at $428.3 million, up 18.0% from FY2024.

  • Annual Other Accumulated Expenses shows a five-year compound annual growth rate of 6.2% (FY2020 to FY2025).
  • In prior years, Vertex Pharmaceuticals' Other Accumulated Expenses was $363 million in FY2024 (-31.1%), $527.2 million in FY2023 (+69.2%), $311.5 million in FY2022 (+16.1%) and $268.4 million in FY2021 (-15.4%).
  • The Q3 2026 figure stands as the lowest quarterly Other Accumulated Expenses since Q2 2024.
  • On a year-over-year basis, Other Accumulated Expenses increased in four of the last eight quarters, with an average decline of 3.6%.
  • The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q1 2024, with growth of 72.0%; the weakest was Q1 2025, with a decline of 40.4%.
  • According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $329.4 million (Q2 2026), $407.1 million (Q1 2026) and $428.3 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Vertex Pharmaceuticals 136.55 Bn 104.28 Bn 2.91 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 293.00 Mn
Jun 30, 2026 329.40 Mn
Mar 31, 2026 407.10 Mn
Dec 31, 2025 428.30 Mn
Sep 30, 2025 441.50 Mn
Jun 30, 2025 425.40 Mn
Mar 31, 2025 386.40 Mn
Dec 31, 2024 363.00 Mn
Sep 30, 2024 357.60 Mn
Jun 30, 2024 279.30 Mn
Mar 31, 2024 648.60 Mn
Dec 31, 2023 527.20 Mn
Sep 30, 2023 316.20 Mn
Jun 30, 2023 391.00 Mn
Mar 31, 2023 377.00 Mn
Dec 31, 2022 311.50 Mn
Sep 30, 2022 218.00 Mn
Jun 30, 2022 238.70 Mn
Mar 31, 2022 286.10 Mn
Dec 31, 2021 268.40 Mn
API Access

Vertex Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=VRTX&period=max&api_key=YOUR_API_KEY